128 related articles for article (PubMed ID: 31740519)
21. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
[TBL] [Abstract][Full Text] [Related]
22. The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas.
Murphy G; Kamangar F; Dawsey SM; Stanczyk FZ; Weinstein SJ; Taylor PR; Virtamo J; Abnet CC; Albanes D; Freedman ND
J Natl Cancer Inst; 2011 Jul; 103(14):1123-9. PubMed ID: 21693726
[TBL] [Abstract][Full Text] [Related]
23. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
[TBL] [Abstract][Full Text] [Related]
24. Plasma hepatocyte growth factor elevation may be associated with early metastatic disease in primary lung cancer patients.
Hosoda H; Izumi H; Tukada Y; Takagiwa J; Chiaki T; Yano M; Arai H
Ann Thorac Cardiovasc Surg; 2012; 18(1):1-7. PubMed ID: 21959198
[TBL] [Abstract][Full Text] [Related]
25. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.
Kikuchi S; Crabtree JE; Forman D; Kurosawa M
Am J Gastroenterol; 1999 Dec; 94(12):3455-9. PubMed ID: 10606302
[TBL] [Abstract][Full Text] [Related]
26. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
27. Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.
Kubo Y; Fukushima S; Inamori Y; Tsuruta M; Egashira S; Yamada-Kanazawa S; Nakahara S; Tokuzumi A; Miyashita A; Aoi J; Kajihara I; Tomita Y; Wakamatsu K; Jinnin M; Ihn H
J Dermatol Sci; 2019 Jan; 93(1):33-40. PubMed ID: 30318169
[TBL] [Abstract][Full Text] [Related]
28. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.
Taniguchi T; Kitamura M; Arai K; Iwasaki Y; Yamamoto Y; Igari A; Toi M
Br J Cancer; 1997; 75(5):673-7. PubMed ID: 9043023
[TBL] [Abstract][Full Text] [Related]
29. IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer.
de la Cruz-Herrera CF; Flores-Luna L; Gutierrez-Xicotencatl L; Chihu-Amparan L; Sánchez-Aleman MA; Lazcano-Ponce E; Torres J; Ayala G
J Med Microbiol; 2013 Apr; 62(Pt 4):591-598. PubMed ID: 23288428
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions.
Con SA; Valerín AL; Takeuchi H; Con-Wong R; Con-Chin VG; Con-Chin GR; Yagi-Chaves SN; Mena F; Brenes Pino F; Echandi G; Kobayashi M; Monge-Izaguirre M; Nishioka M; Morimoto N; Sugiura T; Araki K
J Gastroenterol; 2006 Jul; 41(7):632-7. PubMed ID: 16932999
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases.
Wang C; Xi W; Ji J; Cai Q; Zhao Q; Jiang J; Zhou C; Shi M; Zhang H; Zhu Z; Zhang J
Int J Med Sci; 2020; 17(13):1946-1955. PubMed ID: 32788873
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.
Yong X; Tang B; Li BS; Xie R; Hu CJ; Luo G; Qin Y; Dong H; Yang SM
Cell Commun Signal; 2015 Jul; 13():30. PubMed ID: 26160167
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response.
Churin Y; Al-Ghoul L; Kepp O; Meyer TF; Birchmeier W; Naumann M
J Cell Biol; 2003 Apr; 161(2):249-55. PubMed ID: 12719469
[TBL] [Abstract][Full Text] [Related]
34. STAT3 polymorphism and Helicobacter pylori CagA strains with higher number of EPIYA-C segments independently increase the risk of gastric cancer.
Rocha GA; Rocha AM; Gomes AD; Faria CL; Melo FF; Batista SA; Fernandes VC; Almeida NB; Teixeira KN; Brito KS; Queiroz DM
BMC Cancer; 2015 Jul; 15():528. PubMed ID: 26186918
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
37. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
Yamaoka Y; Kodama T; Kashima K; Graham DY
J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
[TBL] [Abstract][Full Text] [Related]
38. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes.
Sicinschi LA; Lopez-Carrillo L; Camargo MC; Correa P; Sierra RA; Henry RR; Chen J; Zabaleta J; Piazuelo MB; Schneider BG
Int J Cancer; 2006 Feb; 118(3):649-57. PubMed ID: 16114018
[TBL] [Abstract][Full Text] [Related]
39. Genetic susceptibility on CagA-interacting molecules and gene-environment interaction with phytoestrogens: a putative risk factor for gastric cancer.
Yang JJ; Cho LY; Ko KP; Shin A; Ma SH; Choi BY; Han DS; Song KS; Kim YS; Lee JY; Han BG; Chang SH; Shin HR; Kang D; Yoo KY; Park SK
PLoS One; 2012; 7(2):e31020. PubMed ID: 22383989
[TBL] [Abstract][Full Text] [Related]
40. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
